MOG and myeloid sarcoma: Suitable disease-specific autoantigens such as insulin and glutamic acid decarboxylase 65 (GAD65) or transgenic myelin oligodendrocyte glycoprotein (MOG) or myelin basic protein have been defined in DM1 and MS, respectively (128, 129).